Highlights
- Rubicon Research shares gained 1.64% during Thursday's trading session on the NSE.
- The company reported consolidated net profit of INR 7,678.50 lakh for March 2026 quarter.
- The stock has surged more than 109% on a year-to-date basis.
Rubicon Research Limited (NSE:RUBICON) ended the trading session on June 25, 2026, at INR 1,415.00, up INR 22.80 or 1.64% from the previous close. The stock's official closing price stood at INR 1,416.60, compared with the previous close of INR 1,392.20.
The stock opened at INR 1,399.00 and touched an intraday high of INR 1,423.00 before easing slightly. The day's low stood at INR 1,385.00, while the volume weighted average price (VWAP) was INR 1,410.63.
Trading Activity and Market Capitalisation
Rubicon Research recorded traded volume of 2.69 lakh shares during the session, with a traded value of INR 38.01 crore.
The company's total market capitalisation stood at INR 23,401.66 crore, while the free-float market capitalisation was INR 3,216.68 crore. The stock reported an impact cost of 0.08%, and 50.97% of the traded quantity was marked for delivery.
According to exchange data, the stock is listed in the NIFTY IPO index and currently remains under ASM-1 surveillance.
Stock Performance Across Timeframes
Rubicon Research has outperformed the broader market across multiple periods. Over the past week, the stock gained 3.91%, while the NIFTY Total Market index declined 0.15%. During the past month, the stock advanced 44.72%, significantly outperforming the benchmark index, which gained 1.11%.
On a year-to-date basis, Rubicon Research has surged 109.16%, compared with a 2.81% decline in the NIFTY Total Market index. The stock reached its 52-week high of INR 1,468.70 on June 24, 2026, while the 52-week low of INR 570.75 was recorded on October 24, 2025.
March 2026 Financial Performance
For the quarter ended March 31, 2026, Rubicon Research reported audited consolidated total income of INR 51,652.50 lakh. Consolidated profit before tax stood at INR 9,868.70 lakh, while consolidated net profit came in at INR 7,678.50 lakh. Earnings per share (EPS) for the quarter was INR 4.66.
On a standalone basis, total income stood at INR 39,345.90 lakh. Standalone profit before tax was INR 9,418.50 lakh, while net profit came in at INR 7,002.00 lakh. Standalone earnings per share was INR 4.25.
Valuation and Listing Details
Rubicon Research operates in the pharmaceuticals industry and has been listed on the National Stock Exchange since October 16, 2025.
The exchange data indicates that the scrip's price-to-earnings ratio remained above 50 for the previous four trailing quarters. However, the symbol P/E and adjusted P/E are currently displayed as not available.
Key Risks
- Regulatory approvals may affect product launches and revenue.
- Pricing pressure could influence pharmaceutical profit margins.
- ASM surveillance may contribute to higher share price volatility.
- Premium valuation may increase downside during market corrections.
Summary
Rubicon Research shares gained 1.64% on June 25, 2026, extending their year-to-date return to 109.16%. The company reported consolidated net profit of INR 7,678.50 lakh for the March 2026 quarter. The stock remains under ASM-1 surveillance, is part of the NIFTY IPO index, and recently touched its 52-week high on June 24, 2026.
FAQs
Q: What was Rubicon Research's share price on June 25, 2026?
A: Rubicon Research ended the session at INR 1,415.00, while the official closing price was INR 1,416.60.
Q: What were Rubicon Research's March 2026 quarterly financial results?
A: The company reported consolidated total income of INR 51,652.50 lakh and consolidated net profit of INR 7,678.50 lakh.
Q: How has Rubicon Research stock performed in 2026?
A: The stock has gained 109.16% on a year-to-date basis, outperforming the NIFTY Total Market index.